Symposier - AIM-HIGH Stopped: No Benefit of Niacin
Links shared publicly online about this topic.
- 253total visits
Symposier - AIM-HIGH Stopped: No Benefit of Niacin
View full resource at symposier.com
Tags: Cholesterol, Vitamin, Clinical Trial, National Institutes of Health, Niaspan, News
Most Recently Shared on April 3, 2012 at 3:44 pm By:
AIM-HIGH (clinical trial on combination cholesterol treatment) Stopped: No Benefit of Niacin. http://t.co/4pw0WHhn
NIH stops study of niacin to prevent heart attacks | 13abc.com
abclocal.go.com — “A drug that boosts people's good cholesterol didn't go on to prevent heart attacks or strokes, leading U.S. officials to abruptly halt a major study Thursday.” View full resource at abclocal.go.com
Most Recently Shared on May 27, 2011 at 12:01 am By:
Neil Mehta Physician, Doctor, Internist, and Medical Technology
http://bit.ly/m8hYhD Niaspan study stopped early - in spite of HDL increase no CV benefit and increase stroke risk!
Trial Stopped After Niacin Brings No Benefit to Heart Patients --Doctors Lounge
doctorslounge.com — “Trial Stopped After Niacin Brings No Benefit to Heart Patients --Doctors Lounge” View full resource at doctorslounge.com
Most Recently Shared on May 26, 2011 at 10:21 pm By:
Trial Stopped After Niacin Brings No Benefit to Heart Patients: NIH terminated study 18 months early, citing no... http://bit.ly/kXGM8Q
Trial Stopped After Niacin Brings No Benefit to Heart Patients - Drugs.com MedNews
drugs.com — “Although early research had suggested that the nutrient niacin might raise levels of good cholesterol and thwart heart attacks, a major clinical trial has been” View full resource at drugs.com
Most Recently Shared on May 26, 2011 at 7:13 pm By:
Drugs and Devices OW OW Health
Trial Stopped After Niacin Brings No Benefit to Heart Patients: THURSDAY, May 26 -- Although early researc... http://bit.ly/ltMGKj #drug
Trial Stopped After Niacin Brings No Benefit to Heart Patients - MSN Health - Heart & Cardiovascular
health.msn.com — “NIH terminated study 18 months early citing no drop in heart attacks strokes for users” View full resource at health.msn.com
Most Recently Shared on May 26, 2011 at 6:38 pm By:
Trial Stopped After Niacin Brings No Benefit to Heart Patients: http://on-msn.com/m9tG1Q
HDL-Raising Drug Fails To Show Benefit In Government Study - Matthew Herper - The Medicine Show - Forbes
blogs.forbes.com — “The National Heart Lung and Blood Institute stopped a large clinical trial of prescription niacin, which raises high density lipoprotein, the "good cholesterol," because the drug failed to prevent heart attacks and strokes. That's bad news for Abbott Laboratories, which sells Niaspan, the most-used niacin, and Merck, which is developing a [...]” View full resource at blogs.forbes.com
Most Recently Shared on May 26, 2011 at 4:30 pm By:
Drugs and Devices OW OW Health
HDL-Raising Drug Fails To Show Benefit In Government Study: In a big surprise, Niaspan fails to prevent... http://onforb.es/lwxqKU #drug
Symposier - A womans age associated with differing long-term health risks and benefits after estrogen-only therapy.
symposier.com — “Uploaded and shared in Youtube by: TheJAMAReport --" In 2004, the Women's Health Initiative Estrogen-Only Trial was stopped one year early because of an increased risk of stroke and no overall health benefit for the postmenopausal women who had hysterectomies taking the medication. A new long-term study continued following many of the women after they stopped the estrogen and finds that their age was associated with certain ongoing health risks and benefits long after taking the last pill. ” View full resource at symposier.com
Most Recently Shared on April 13, 2011 at 9:06 pm By:
Symposier Endocrino Health Site
A womans age associated with differing long-term health risks and benefits after estrogen-only therapy. http://bit.ly/eUmunk
Advertisement
